BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30661991)

  • 1. Stabilization of lncRNA GAS5 by a Small Molecule and Its Implications in Diabetic Adipocytes.
    Shi Y; Parag S; Patel R; Lui A; Murr M; Cai J; Patel NA
    Cell Chem Biol; 2019 Mar; 26(3):319-330.e6. PubMed ID: 30661991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a macrocyclic γ-AApeptide binding to lncRNA GAS5 and its therapeutic implication in Type 2 diabetes.
    Shi Y; Patel NA; Cai J
    Future Med Chem; 2019 Sep; 11(17):2233-2235. PubMed ID: 31581909
    [No Abstract]   [Full Text] [Related]  

  • 3. GAS5 long non-coding RNA in malignant pleural mesothelioma.
    Renganathan A; Kresoja-Rakic J; Echeverry N; Ziltener G; Vrugt B; Opitz I; Stahel RA; Felley-Bosco E
    Mol Cancer; 2014 May; 13():119. PubMed ID: 24885398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of Long Noncoding RNA Gas5 Affects Cell Cycle and Insulin Secretion in Mouse Pancreatic β Cells.
    Jin F; Wang N; Zhu Y; You L; Wang L; De W; Tang W
    Cell Physiol Biochem; 2017; 43(5):2062-2073. PubMed ID: 29232661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GAS5: A pivotal lncRNA in diabetes mellitus pathogenesis and management.
    Alharbi KS
    Pathol Res Pract; 2024 Jan; 253():154955. PubMed ID: 38016351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA GAS5 inhibits cell proliferation and fibrosis in diabetic nephropathy by sponging miR-221 and modulating SIRT1 expression.
    Ge X; Xu B; Xu W; Xia L; Xu Z; Shen L; Peng W; Huang S
    Aging (Albany NY); 2019 Oct; 11(20):8745-8759. PubMed ID: 31631065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between the Deletion Allele of Ins/Del Polymorphism (Rs145204276) in the Promoter Region of GAS5 with the Risk of Atherosclerosis.
    Shen Z; She Q
    Cell Physiol Biochem; 2018; 49(4):1431-1443. PubMed ID: 30205366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating long noncoding RNAs H19 and GAS5 are associated with type 2 diabetes but not with diabetic retinopathy: A preliminary study.
    Fawzy MS; Abdelghany AA; Toraih EA; Mohamed AM
    Bosn J Basic Med Sci; 2020 Aug; 20(3):365-371. PubMed ID: 31999937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the LncRNA GAS5-MiR-23a-ATG3 Axis in Regulating Autophagy in Patients with Breast Cancer.
    Gu J; Wang Y; Wang X; Zhou D; Wang X; Zhou M; He Z
    Cell Physiol Biochem; 2018; 48(1):194-207. PubMed ID: 30007957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA GAS5 regulates vascular smooth muscle cell cycle arrest and apoptosis via p53 pathway.
    Tang R; Mei X; Wang YC; Cui XB; Zhang G; Li W; Chen SY
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2516-2525. PubMed ID: 31167125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of Long Non-Coding RNA GAS5 Increases miR-23a by Targeting ATG3 Involved in Autophagy and Cell Viability.
    Li L; Huang C; He Y; Sang Z; Liu G; Dai H
    Cell Physiol Biochem; 2018; 48(4):1723-1734. PubMed ID: 30078013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecule targeting long noncoding RNA GAS5 administered intranasally improves neuronal insulin signaling and decreases neuroinflammation in an aged mouse model.
    Patel RS; Lui A; Hudson C; Moss L; Sparks RP; Hill SE; Shi Y; Cai J; Blair LJ; Bickford PC; Patel NA
    Sci Rep; 2023 Jan; 13(1):317. PubMed ID: 36609440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA GAS5 attenuates cardiac fibroblast proliferation in atrial fibrillation via repressing ALK5.
    Lu J; Xu FQ; Guo JJ; Lin PL; Meng Z; Hu LG; Li J; Li D; Lu XH; An Y
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7605-7610. PubMed ID: 31539152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long Non-coding RNAs RN7SK and GAS5 Regulate Macrophage Polarization and Innate Immune Responses.
    Ahmad I; Valverde A; Naqvi RA; Naqvi AR
    Front Immunol; 2020; 11():604981. PubMed ID: 33362791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low expression of lncRNA-GAS5 is implicated in human primary varicose great saphenous veins.
    Li L; Li X; The E; Wang LJ; Yuan TY; Wang SY; Feng J; Wang J; Liu Y; Wu YH; Ma XE; Ge J; Cui YY; Jiang XY
    PLoS One; 2015; 10(3):e0120550. PubMed ID: 25806802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis.
    Long X; Song K; Hu H; Tian Q; Wang W; Dong Q; Yin X; Di W
    J Exp Clin Cancer Res; 2019 Aug; 38(1):345. PubMed ID: 31391118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Berberine Acts on C/EBPβ/lncRNA Gas5/miR-18a-5p Loop to Decrease the Mitochondrial ROS Generation in HK-2 Cells.
    Xu J; Liu L; Gan L; Hu Y; Xiang P; Xing Y; Zhu J; Ye S
    Front Endocrinol (Lausanne); 2021; 12():675834. PubMed ID: 34526965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sweetening the Therapeutic Pot for Type 2 Diabetes with Long Noncoding RNAs.
    Dickson P; Kodadek T
    Cell Chem Biol; 2019 Mar; 26(3):311-313. PubMed ID: 30901557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long non-coding RNA GAS5 regulates transforming growth factor β (TGF-β)-induced smooth muscle cell differentiation via RNA Smad-binding elements.
    Tang R; Zhang G; Wang YC; Mei X; Chen SY
    J Biol Chem; 2017 Aug; 292(34):14270-14278. PubMed ID: 28659340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating long noncoding RNA GAS5 levels are correlated to prevalence of type 2 diabetes mellitus.
    Carter G; Miladinovic B; Patel AA; Deland L; Mastorides S; Patel NA
    BBA Clin; 2015 Dec; 4():102-7. PubMed ID: 26675493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.